32,909 Shares in STERIS plc (NYSE:STE) Acquired by Sone Capital Management LLC

Sone Capital Management LLC bought a new stake in STERIS plc (NYSE:STE) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 32,909 shares of the medical equipment provider’s stock, valued at approximately $6,765,000.

A number of other institutional investors also recently added to or reduced their stakes in the company. Select Equity Group L.P. raised its holdings in shares of STERIS by 165.3% in the 4th quarter. Select Equity Group L.P. now owns 2,599,730 shares of the medical equipment provider’s stock valued at $534,400,000 after purchasing an additional 1,619,796 shares in the last quarter. Norges Bank purchased a new position in STERIS in the fourth quarter valued at $238,836,000. Raymond James Financial Inc. purchased a new position in STERIS in the fourth quarter valued at $223,987,000. Franklin Resources Inc. raised its stake in STERIS by 45.1% in the fourth quarter. Franklin Resources Inc. now owns 1,216,821 shares of the medical equipment provider’s stock valued at $250,130,000 after buying an additional 378,252 shares in the last quarter. Finally, Wellington Management Group LLP lifted its holdings in STERIS by 4,534.6% during the 4th quarter. Wellington Management Group LLP now owns 219,032 shares of the medical equipment provider’s stock worth $45,024,000 after buying an additional 214,306 shares during the last quarter. Hedge funds and other institutional investors own 94.69% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently commented on the company. Piper Sandler increased their price objective on STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a report on Monday, February 3rd. JMP Securities increased their price target on shares of STERIS from $265.00 to $280.00 and gave the company a “market outperform” rating in a research note on Friday. Needham & Company LLC reissued a “hold” rating on shares of STERIS in a report on Monday, April 7th. Citigroup restated an “outperform” rating on shares of STERIS in a research report on Friday. Finally, Stephens reaffirmed an “overweight” rating and issued a $250.00 target price on shares of STERIS in a research report on Thursday. One investment analyst has rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $265.00.

STERIS Trading Up 2.1%

NYSE:STE opened at $252.12 on Monday. The company has a market capitalization of $24.77 billion, a PE ratio of 53.53 and a beta of 0.96. STERIS plc has a 52-week low of $200.98 and a 52-week high of $252.20. The stock’s 50 day moving average price is $224.13 and its 200 day moving average price is $219.31. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32.

STERIS (NYSE:STE) last announced its earnings results on Wednesday, May 14th. The medical equipment provider reported $2.74 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.59 by $0.15. The business had revenue of $1.48 billion for the quarter, compared to analyst estimates of $1.47 billion. STERIS had a net margin of 8.66% and a return on equity of 13.91%. The company’s revenue for the quarter was up 5.7% compared to the same quarter last year. During the same period last year, the firm posted $2.58 earnings per share. On average, research analysts anticipate that STERIS plc will post 9.08 EPS for the current year.

STERIS Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 26th. Shareholders of record on Tuesday, June 10th will be paid a $0.57 dividend. The ex-dividend date of this dividend is Tuesday, June 10th. This represents a $2.28 dividend on an annualized basis and a yield of 0.90%. STERIS’s dividend payout ratio is presently 36.77%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.